Video

Dr. Lai on Risk Factors Associated With Glioma

Author(s):

Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case Control study.

Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case-Control Study.

In the study, which investigated risk factors in 4000 newly diagnosed patients with glioma, researchers sought to determine whether aspirin or non-steroidal anti-inflammatory agents (NSAIDs) were associated with a risk of disease. Earlier, smaller studies also looking at the association have demonstrated conflicting results, Lai says. However, recent evidence suggests that aspirin is associated with a lower risk of glioma.

Results of this study showed that aspirin was linked with a significant protective effect for patients with glioma; however, NSAIDs were only associated with reduced glioma risk in women.

<<<

View more from the 2016 AACR Annual Meeting

Related Videos
Funda Meric-Bernstam, MD
Laurence Albigès, MD, PhD
Nirav Shah, MD, MSHP, discusses evaluating zamtocabtagene autoleucel in patients with relapsed/refractory diffuse large B-cell lymphoma.
Bhagirathbhai Dholaria, MBBS
Sairah Ahmed, M.D
Barry W. Goy, MD
Fred Saad, CQ, MD, FRCS, FCAHS, director, Prostate Cancer Research, Montreal Cancer Institute, Centre Hospitalier de l’Université de Montréal; full professor, Department of Surgery, Université de Montréal; uro-oncologist, Urology Department, University of Montreal Health Center
Manmeet Singh Ahluwalia, MD, MBA, FASCO, chief scientific officer, chief, medical oncology, deputy director, Fernandez Family Endowed Chair in Cancer Research, Baptist Health Miami Cancer Institute
Kelly E. McCann, MD, PhD, assistant professor, breast medical oncologist, UCLA
Neeta Somaiah, MD